EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma

Sojeong Kim, Haerim Chung, Jeong-Eun Kwak iD, Yu Ri Kim, Chung Hyun Park, Yeonhee Kim, June-Won Cheong, Jennifer Wu, Eui-Cheol Shin iD, Hyunsoo Cho iD, Jin Seok Kim

Journal for ImmunoTherapy of Cancer · 2024

DOI: 10.1136/jitc-2023-007886 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2024. Verfasst von Sojeong Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea (the Republic of). Hauptthemen laut MEDLINE: Multiple Myeloma. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, Yonsei University College of Medicine, Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Major histocompatibility complex (MHC) class I chain-related protein (MIC) is a stress-induced ligand released from multiple myeloma (MM) cells during progression, and soluble MIC impairs natural killer group 2D (NKG2D) activating receptor-mediated recognition and function of natural killer (NK) cells. However, whether clearing soluble MIC with a monoclonal antibody (mAb) can restore NK cell activity of MM patients remains undetermined.

Methods

We analyzed The Cancer Genome Atlas (TCGA) Multiple Myeloma Research Foundation (MMRF) CoMMpass data set to examine the prognostic significance of MIC expression in MM. We examined the level of soluble MIC in paired peripheral blood (PB) and bone marrow (BM) plasma of patients with MM at diagnosis by ELISA. We evaluated the correlation between the level of soluble MIC and immunophenotype of NK cells from MM patients by multicolor flow cytometry. We also generated MIC-overexpressing MM cell line and characterized the cytotoxic function of patient NK cells in the presence of soluble MIC, and examined the impact of clearing soluble MIC with a humanized mAb (huB10G5).

Results

We characterize the importance of MICA in MM by revealing the significantly better overall survival of patients with high MICA expression from TCGA MMRF CoMMpass data set. The level of soluble MICA is more highly elevated in MM than in precursor stages, and the concentration of soluble MICA is higher in BM plasma than in PB. The concentration of soluble MICA in BM was correlated with myeloma burden, while it was negatively correlated with the frequency of NKG2D + NK cells in diagnostic BM aspirates of MM patients. Soluble MICA downregulated NKG2D expression and decreased cytotoxicity of MM patient NK cells ex vivo , which were reversed by a humanized soluble MIC-clearing mAb (huB10G5) with enhanced degranulation of NK cells.

Conclusions

Our findings indicate targeting soluble MIC with huB10G5 might be a viable therapeutic approach to promote NKG2D-dependent cellular immunotherapy outcome in MM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaHumansNK Cell Lectin-Like Receptor Subfamily KKiller Cells, NaturalAntibodies, MonoclonalAntibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

ImmunityImmunotherapy

Substanzen

NK Cell Lectin-Like Receptor Subfamily KAntibodies, MonoclonalAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea (the Republic of).
  • Department of Urology and Department of Microbiology and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea (the Republic of) hyunsoocho@yuhs.ac hemakim@yuhs.ac ecshin@kaist.ac.kr.
  • Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea (the Republic of) hyunsoocho@yuhs.ac hemakim@yuhs.ac ecshin@kaist.ac.kr.

ORCID-Profile: Jeong-Eun Kwak, Eui-Cheol Shin, Hyunsoo Cho

Förderung

  • NCI NIH HHS
  • Yonsei University College of Medicine
  • Korea Health Industry Development Institute
  • Ministry of Science and ICT, Republic of Korea

Zitieren

APA

Kim, S., Chung, H., Kwak, J. E., Kim, Y. R., Park, C. H., Kim, Y., Cheong, J. W., Wu, J., Shin, E. C., Cho, H., & Kim, J. S. (2024). Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2023-007886

Vancouver

Kim S, Chung H, Kwak JE, Kim YR, Park CH, Kim Y, et al. Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma. Journal for ImmunoTherapy of Cancer. 2024. doi:10.1136/jitc-2023-007886

BibTeX
@article{Kim2024,
  author = {Kim, Sojeong and Chung, Haerim and Kwak, Jeong-Eun and Kim, Yu Ri and Park, Chung Hyun and Kim, Yeonhee and Cheong, June-Won and Wu, Jennifer and Shin, Eui-Cheol and Cho, Hyunsoo and Kim, Jin Seok},
  title = {Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2024},
  doi = {10.1136/jitc-2023-007886}
}
Kostenlos starten →